Page last updated: 2024-08-24

halofuginone and Osteoarthritis

halofuginone has been researched along with Osteoarthritis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amat, A; Cao, L; Ji, B; Li, J; Ma, H; Mu, W; Xu, B; Zhang, Z1
Bian, Q; Cao, X; Crane, J; Cui, Z; Ding, S; Jin, X; Li, C; Qiu, T; Wan, M; Wang, L; Xie, H; Xie, L; Xie, M; Yu, B; Zhen, G1

Other Studies

2 other study(ies) available for halofuginone and Osteoarthritis

ArticleYear
Halofuginone attenuates articular cartilage degeneration by inhibition of elevated TGF‑β1 signaling in articular cartilage in a rodent osteoarthritis model.
    Molecular medicine reports, 2017, Volume: 16, Issue:5

    Topics: Animals; Anterior Cruciate Ligament; Anti-Inflammatory Agents; Cartilage, Articular; Collagen Type X; Disease Models, Animal; Gene Expression Regulation; Male; Matrix Metalloproteinase 13; Mice; Mice, Inbred C57BL; Osteoarthritis; Piperidines; Quinazolinones; Signal Transduction; Transforming Growth Factor beta1

2017
Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.
    Annals of the rheumatic diseases, 2016, Volume: 75, Issue:9

    Topics: Animals; Anterior Cruciate Ligament; Bone and Bones; Bone Remodeling; Bone Resorption; Cartilage, Articular; Disease Models, Animal; Disease Progression; Male; Mice; Mice, Inbred C57BL; Osteoarthritis; Osteoclasts; Piperidines; Quinazolinones; Random Allocation; Rats; Rats, Inbred Lew; Transforming Growth Factor beta

2016